Frencken Group's Earnings Likely to Recover Further in 2024-2025 -- Market Talk

Dow Jones03-01

0601 GMT - Frencken Group's earnings are likely to recover further in 2024-2025, RHB Research analyst Alfie Yeo says in a research note as RHB raises the stock's target price to S$1.80 from S$1.45 with an unchanged buy rating. Its 2023 earnings outperformed RHB's estimates on order acceleration in its semiconductor segment, for which revenue trends should continue to improve as its key European customer continues to grow and expand into Asia, the analyst says. Also, the Singapore-listed technology solutions provider's positive revenue outlook will probably be supported by the medical segment, where topline is poised to increase on more robust customer orders, the analyst adds. Shares are 1.9% higher at S$1.63. (ronnie.harui@wsj.com)

 

(END) Dow Jones Newswires

March 01, 2024 01:01 ET (06:01 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment